Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Never miss a story — sign up for PEOPLE's free daily newsletter to stay up-to-date on the best of what ... In March, the weight loss drug Wegovy was FDA-approved to prevent strokes and heart ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

The Food and Drug Administration approved Eli Lilly’s ... the condition by reducing body weight, according to the FDA. The move comes as weight-loss medications have garnered immense national ...

Each brand has its own formula for helping users achieve their weight loss goals. Their methods include remote healthcare ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity.

The U.S. Food and Drug Administration (FDA) recently approved Zepbound® (tirzepatide ... OSA symptoms while also promoting significant weight loss. Zepbound is an injectable prescription ...